靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Allergen BioCube Study Evaluating the Efficacy and Safety of Nasapaque Nasal Solution in a Population of Adult Subjects With Seasonal Allergic Rhinitis
Single-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy and safety study using the Allergen BioCube (ABC).
100 项与 3E Therapeutics Corporation 相关的临床结果
0 项与 3E Therapeutics Corporation 相关的专利(医药)
100 项与 3E Therapeutics Corporation 相关的药物交易
100 项与 3E Therapeutics Corporation 相关的转化医学